Sitomegalovirus Enfeksiyonuna Bağlı Ciddi Trombositopeni

Yıl 2016, Cilt: 1 Sayı: 1, 1 - 7, 15.08.2016

Yasemin Altuner Torun Ayşe Betül Ergül Meriban Karadoğan Fatma Türkan Mutlu

Öz

Sitomegalovirüs (CMV) enfeksiyonu immün sistemi
normal olanlar bireylerde genellikle asemptomatik seyretmekle birlikte nadiren ciddi
klinik tablolar tanımlanmıştır. Sağlıklı erişkinlerde CMV enfeksiyonu sonrası
ciddi trombositopeni gelişen vakalar bildirilmiş olmasına rağmen çocuklarda
bildirilen vaka sayısı azdır.  CMV
enfeksiyonuna bağlı trombositopenide tedavide ilk seçenek steroidlerdir,
bununla birlikte dirençli vakalarda intravenöz immunglobulin (İVİG) tedavisi
oldukça etkili olmaktadır. Biz bu yazıda CMV enfeksiyonu sonrasında   trombositopeni
gelişen ve  İVİG tedavisine dramatik
yanıt alınan  bir çocuk hastayı sunduk.

Abstract

Cytomegalovirus (CMV) infection is generally
asymptomatic in the immunocompetent  hosts
and rarely defined as a severe clinical situation . However there have been
several case reports of trombocytopenia after CMV infections in adults,  there are few reports about pediatric cases. The
first choice in trombocytopenia related with CMV infections is streroids,  in refractory cases  intravenous
immunoglobulin (IVIG) therapy is very effective. In this article  we describe a pediatric patient  who has trombocytopenia after CMV infection
and be dramatically treated by IVIG therapy.

Anahtar Kelimeler

sitomegalovirüs, trombositopeni, intravenöz immunglobulin

Kaynakça

• 10. Yaari S, Koslowsky B, Wolf D, Chajek-Shaul T, Hershcovici T. CMV-related thrombocytopenia treated with foscarnet: a case series and review of the literature. Platelets 2010;21:490-5.
• 9. Eisenberg MJ, Kaplan B. Cytomegalovirus-induced thrombocytopenia in an immunocompetent adult. West J Med 1993;158:525-6.
• 8. Wu Z, Zhou J, Wei X, Wang X, Li Y, Peng B, Niu T. The role of Epstein-Barr virus (EBV) and cytomegalovirus (CMV) in immune thrombocytopenia. Hematology 2013;18:295-9.
• 7. Europea Sugioka T, Kubota Y, Wakayama K, Kimura S. Severe steroid-resistant thrombocytopenia secondary to cytomegalovirus infection in an immunocompetent adult. Intern Med 2012;51:1747-50.
• 6. Ichiche M, Fontaine C, Lacor P. Severe thrombocytopenia secondary to cytomegalovirus infection in an immunocompetent adult. Eur J Intern Med 2003;14:56-59.
• 5. Rafailidis PI, Mourtzoukou EG, Varbobitis IC, Falagas ME. Severe cytomegalovirus infection in apparently immunocompetent patients: a systematic review. Virol J 2008;5:47.
• 4. Schleiss MR. Cytomegalovirus in the Neonate: Immune Correlates of Infection and Protection. Clin Dev Immunol 2013;2013:501801.
• 3. Sakata H, Ikegami K, Nagaya K, Shirai M, Maruyama S. Thrombocytopenia caused by acquired cytomegalovirus infection in children. Pediatr Int 1999;41:113-4.
• 2. Taylor GH. Cytomegalovirus. Am Fam Physician 2003;67:519-24.
• 1. Liberekacdf A, Rytlewskabe M, Szlagatys-Sidorkiewiczbc A, Bakoab et al. Cytomegalovirus disease in neonates and infants clinical presentation, diagnostic and therapeuticproblems – own experience Med Sci Monit 2002;8:CR815-20.